Disparities in the Use of Guideline-Based Pharmacotherapy Exist for Atherosclerotic Cardiovascular Disease and Heart Failure Patients Who Have Intellectual/Developmental Disabilities in a Commercially Insured Database
Restricted accessResearch articleFirst published online October, 2020
Disparities in the Use of Guideline-Based Pharmacotherapy Exist for Atherosclerotic Cardiovascular Disease and Heart Failure Patients Who Have Intellectual/Developmental Disabilities in a Commercially Insured Database
Patients who have intellectual/developmental disabilities (IDDs) develop atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF) at rates similar to or higher than the general population. They also face disparities accessing and using health care services.
Objective:
To determine if disparities exist in the use of guideline-based pharmacotherapy (GBP) for ASCVD or HF for adults with IDD.
Methods:
Using the 2014 Clinformatics Data Mart Database, adults with ASCVD or HF were divided into IDD or non-IDD groups. Patients with contraindications for GBP medications were excluded. Use of GBP between IDD and non-IDD groups was examined. Subgroup analysis included comparisons between IDD groups.
Results:
For HF, 1011 patients with IDD and 236,638 non-IDD patients were identified. For ASCVD, 2190 IDD and 790,343 non-IDD patients were identified. We found that 47.9%, 35.8%, and 13.1% of IDD and 58.7%, 48.4%, and 18.9% of non-IDD patients had pharmacy claims for statins (P < 0.001), β-blockers (P < 0.001), or antiplatelet therapy (P < 0.001), respectively. For HF, 46.8% and 50.3% of IDD and 59.8% and 55.4% of non-IDD patients had pharmacy claims for β-blockers (P < 0.001) and angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs; P = 0.003), respectively. In all but one multivariate regression models patients with IDD were less likely to use GBP than patients in the non-IDD group. Subgroup analysis revealed that patients who had Down syndrome had lower GBP use in 4 of the 5 measures.
Conclusion and Relevance:
Disparities exist in the use of GBP for patients with IDD with ASCVD or HF. Patients who have an IDD should be examined by clinicians to ensure appropriate access to and use of GBP.
DraheimCC. Cardiovascular disease prevalence and risk factors of persons with mental retardation. Ment Retard Dev Disabil Res Rev. 2006;12:3-12. doi:10.1002/mrdd.20095
4.
de WinterCFBastiaanseLPHilgenkampTIMEvenhuisHMEchteldMA. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study. Res Dev Disabil. 2012;33:1722-1731. doi:10.1016/j.ridd.2012.04.010
5.
de WinterCFMagilsenKWvan AlfenJCPenningCEvenhuisHM. Prevalence of cardiovascular risk factors in older people with intellectual disability. Am J Intellect Dev Disabil. 2009;114:427-436. doi:10.1352/1944-7558-114.6.427
6.
HendersonCMRobinsonLMDavidsonPWHavemanMJanickiMPAlbertiniG. Overweight status, obesity, and risk factors for coronary heart disease in adults with intellectual disability. J Policy Pract Intellect Disabil. 2008;5:174-177. doi:10.1111/j.1741-1130.2008.00170.x
7.
WallaceRASchluterP. Audit of cardiovascular disease risk factors among supported adults with intellectual disability attending an ageing clinic. J Intellect Dev Disabil. 2008;33:48-58. doi:10.1080/13668250701858463
8.
KrahnGLHammondLTurnerA. A cascade of disparities: health and health care access for people with intellectual disabilities. Ment Retard Dev Disabil Res Rev. 2006;12:70-82. doi:10.1002/mrdd.20098
9.
PetersonMDRyanJMHurvitzEAMahmoudiE. Chronic conditions in adults with cerebral palsy. JAMA. 2015;314:2303-2305. doi:10.1001/jama.2015.11025
10.
YancyCWJessupMBozkurtB, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327. doi:10.1016/j.jacc.2013.05.019
11.
YancyCWJessupMBozkurtB, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137-e161. doi:10.1161/CIR.0000000000000509
12.
FihnSDGardinJMAbramsJ, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44-e164. doi:10.1161/CIR.0b013e3182776f83
13.
LevineDMLinderJALandonBE. The quality of outpatient care delivered to adults in the United States, 2002 to 2013. JAMA Intern Med. 2016;176:1778-1790. doi:10.1001/jamainternmed.2016.6217
14.
JiaoSMurimiIBStaffordRSMojtabaiRAlexanderGC. Quality of prescribing by physicians, nurse practitioners, and physician assistants in the United States. Pharmacotherapy. 2018;38:417-427. doi:10.1002/phar.2095
15.
EdwardsSTMafiJNLandonBE. Trends and quality of care in outpatient visits to generalist and specialist physicians delivering primary care in the United States, 1997-2010. J Gen Intern Med. 2014;29:947-955. doi:10.1007/s11606-014-2808-y
16.
MeidADQuinzlerRGrollA, et al. Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. Eur J Clin Pharmacol. 2016;72:877-885. doi:10.1007/s00228-016-2047-8
17.
MeidADQuinzlerRFreigofasJ, et al. Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS One. 2015;10:e0136339. doi:10.1371/journal.pone.0136339
18.
BeerCHydeZAlmeidaOP, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol. 2011;71:592-599. doi:10.1111/j.1365-2125.2010.03875.x
19.
EricksonSRSpoutzPDorschMBleskeB. Cardiovascular risk and treatment for adults with intellectual or developmental disabilities. Int J Cardiol. 2016;221:371-375. doi:10.1016/j.ijcard.2016.07.044
20.
HoveOBiringerEHavikOE, et al. Prevalence of drug use among adults with intellectual disabilities compared with drug use in the general population. Pharmacoepidemiol Drug Saf. 2019;28:337-344. doi:10.1002/pds.4741
21.
LuZCoganLMcDermottS, et al. Disparities in diabetes management among Medicaid recipients with intellectual and developmental disabilities (IDD): evidence from five US states. Disabil Health J. 2019;13(2):100880. doi:10.1016/j.dhjo.2019.100880
22.
MaJStaffordRS. Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med. 2005;165:1354-1361. doi:10.1001/archinte.165.12.1354
23.
McGlynnEAAschSMAdamsJ, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645. doi:10.1056/NEJMsa022615
24.
McLaughlinTJSoumeraiSBWilkisonDJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for under treatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
25.
GanzDALamasGAOravEJGoldmanLGutierrezPRMangioneCM. Age-related differences in management of heart disease: a study of cardiac medication use in an older cohort. Pacemaker Selection in the Elderly (PASE) Investigators. J Am Geriatr Soc. 1999;47:145-150. doi:10.1111/j.1532-5415.1999.tb04571.x
26.
AdesPA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892-902. doi:10.1056/NEJMra001529
27.
MassingMWFoleyKACarter-EdwardsLSuetaCAAlexanderCMSimpsonRJJr.Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord. 2004;18:4-15. doi:10.1186/1471-2261-4-15
28.
ZhangHPlutzkyJShubinaMTurchinA. Drivers of the sex disparity in statin therapy in patients with coronary artery disease: a cohort study. PLoS One. 2016;11:e0155228. doi:10.1371/journal.pone.0155228
29.
HowellsG. Are the medical needs of the mentally handicapped adults being met?J R Coll Gen Pract. 1986;36:449-453.
30.
KastnerTWalshKCriscioneT. Policy issues in health care reform for people with mental retardation. In: US Department of Health and Human Services, President’s Commission on Mental Retardation, eds. The National Reform Agenda and People With Mental Retardation: Putting People First. Washington, DC: President’s Commission on Mental Retardation; 1994:53-71.
31.
LennoxNGKerrMP. Primary health care and people with an intellectual disability: the evidence base. J Intellect Disabil Res. 1997;41(pt 5):365-372. doi:10.1111/j.1365-2788.1997.tb00723.x
32.
WilsonDNHaireA. Health care screening for people with mental handicap living in the community. BMJ. 1990;301:1379-1381. doi:10.1136/bmj.301.6765.1379
33.
Ouellette-KuntzH. Understanding health disparities and inequities faced by individuals with intellectual disabilities. J Appl Res Intellect Disabil. 2005;18:113-121. doi:10.1111/j.1468-3148.2005.00240.x
34.
BeangeHLennoxN. Physical aspects of health in the learning disabled. Curr Opin Psychiatry. 1998;11:531-534.
35.
ChoiKHWynneME. Providing services to Asian Americans with developmental disabilities and their families: mainstream service providers’ perspective. Community Ment Health J. 2000;36:589-595.
36.
HoggJ. Essential healthcare for people with learning disabilities: barriers and opportunities. J R Soc Med. 2001;94:333-336. doi:10.1177/014107680109400704
37.
VoelkerR. Improved care for neglected population must be “rule rather than exception.”JAMA. 2002;288:299-301. doi:10.1001/jama.288.3.299
38.
BachPBPhamHHSchragDTateRCHargravesJL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-584. doi:10.1056/NEJMsa040609
39.
TrivediANZaslavskyAMSchneiderECAyanianJZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005;353:692-700. doi:10.1056/NEJMsa051207
40.
SmolinaKBallLHumphriesKHKhanNMorganSG. Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women. Circ Cardiovasc Qual Outcomes. 2015;8:586-592. doi:10.1161/CIRCOUTCOMES.115.001987
41.
Hall-LipsyEChisholm-BurnsMA. Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment. Am J Health Syst Pharm. 2010;67:462-468. doi:10.2146/ajhp090161
42.
LevineDALangaKMGaleckiA, et al. Mild cognitive impairment and receipt of treatments for acute myocardial infarction in older adults. J Gen Intern Med. 2020;35:28-35. doi:10.1007/s11606-019-05155-8
43.
MitchellAJLawrenceD. Revascularization and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatry. 2011;198:434-441. doi:10.1192/bjp.bp.109076950
44.
WilcheskyaMTamblyRMHuangA. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131-141. doi:10.1016/S0895-4356(03)00246-4
45.
QuanHLiBSaundersLD, et al; IMECCHI Investigators. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43:1424-1441. doi:10.1111/j.1475-6773.2007.00822.x
46.
ReevesSGarciaEKleynM, et al. Identifying sickle cell disease cases using administrative claims. Acad Pediatr. 2014;14(5, suppl):S61-S67. doi:10.1016/j.acap.2014.02.008
47.
WhitneyDGWarschauskySANgSHurvitzEAKamdarNSPetersonMD. Prevalence of mental health disorders among adults with cerebral palsy: a cross-sectional analysis. Ann Intern Med. 2019;171:328-333. doi:10.7326/M18-3420
48.
ErvinDAMerrickJ. Intellectual and developmental disability: healthcare financing. Front Public Health. 2014;2:160. doi:10.3389/fpubh. 2014.00160
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
